Webinar: Perfusable 3D Lung-on-a-Chip Models for Translational Research
Studying respiratory diseases, such as interstitial lung diseases, remains a major challenge due to the lack of biologically relevant human lung models that can recapitulate disease processes like irreversible fibrosis. To advance drug discovery for respiratory diseases, more comprehensive 3D in vitro models are needed – ones that go beyond the traditional compartmentalized setups and mimic different cell type and vascular interactions, as well as inflammation and matrix remodeling. At MIMETAS, we develop Airway-on-a-Chip (AoC) models that recapitulate characteristic processes of healthy and diseased states of the human lung. In this webinar, Lenie van den Broek (Director Biology Discovery, MIMETAS) and Artur Rodrigues (Early Stage Researcher, MIMETAS) to explore how our lung models are transforming respiratory research and high-throughput drug testing, with a focus on our newest model, integrating unidirectional flow, perfusable microvascular networks and differentiated airway epithelium. What you will learn in this webinar:
- Discover how the OrganoPlate® platform can be used to model physiologically relevant, 3D lung tumor microenvironments to study immune cell migration
- See how the design of our AoC model enables aerosol exposure to study different triggers and their responses
- Details on our latest advancement: a vascularized lung model with unidirectional, gravity-driven flow that mimics realistic airway fluid dynamics
Webinar: Perfusable 3D Lung-on-a-Chip Models for Translational Research
Webinar: Perfusable 3D Lung-on-a-Chip Models for Translational Research
Watch this webinar, to explore how our lung models are transforming respiratory research and high-throughput drug testing, with a focus on our newest model, integrating unidirectional flow, perfusable microvascular networks and differentiated airway epithelium.
Webinar: Perfusable 3D Lung-on-a-Chip Models for Translational Research
Watch this webinar, to explore how our lung models are transforming respiratory research and high-throughput drug testing, with a focus on our newest model, integrating unidirectional flow, perfusable microvascular networks and differentiated airway epithelium.
Webinar: Perfusable 3D Lung-on-a-Chip Models for Translational Research
Watch this webinar, to explore how our lung models are transforming respiratory research and high-throughput drug testing, with a focus on our newest model, integrating unidirectional flow, perfusable microvascular networks and differentiated airway epithelium.
Webinar: Perfusable 3D Lung-on-a-Chip Models for Translational Research
Watch this webinar, to explore how our lung models are transforming respiratory research and high-throughput drug testing, with a focus on our newest model, integrating unidirectional flow, perfusable microvascular networks and differentiated airway epithelium.
Webinar: Perfusable 3D Lung-on-a-Chip Models for Translational Research
Watch this webinar, to explore how our lung models are transforming respiratory research and high-throughput drug testing, with a focus on our newest model, integrating unidirectional flow, perfusable microvascular networks and differentiated airway epithelium.
Webinar: Perfusable 3D Lung-on-a-Chip Models for Translational Research
Watch this webinar, to explore how our lung models are transforming respiratory research and high-throughput drug testing, with a focus on our newest model, integrating unidirectional flow, perfusable microvascular networks and differentiated airway epithelium.
Webinar: Perfusable 3D Lung-on-a-Chip Models for Translational Research
Watch this webinar, to explore how our lung models are transforming respiratory research and high-throughput drug testing, with a focus on our newest model, integrating unidirectional flow, perfusable microvascular networks and differentiated airway epithelium.
Webinar: Perfusable 3D Lung-on-a-Chip Models for Translational Research
Watch this webinar, to explore how our lung models are transforming respiratory research and high-throughput drug testing, with a focus on our newest model, integrating unidirectional flow, perfusable microvascular networks and differentiated airway epithelium.